ArticleJournal of cancer research and clinical oncology2011

An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma.

Jian-Wen Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.